Duke Energy Price Target Reduced by 5 Amid Market Adjustments Soaring Egg Prices The Cost of UK Household Essentials Since 2022 SP 500 MeltUp Potential Could the Index Reach 8000 or Beyond California Toxic Leak Emergency May Disrupt Chemical Supply Chains UK Social Media Regulation Risk Intensifies as Starmer Vows Action Following Meeting with Bereaved Parents Microsoft and Anthropic Explore AI Chip Collaboration Following 5 Billion Investment APLS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates OESX Q1 2026 Earnings Robust EPS Surprise Highlights Operational Efficiency Gains SRE Q1 2026 Earnings Slight EPS Miss Amid Solid Operational Performance and Positive Market Reaction Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates but Stock Posts Modest Gain Block Inc XYZ Q1 2026 Earnings Strong EPS Beat of 2443 Surprises Markets Shares Dip Slightly BKD Q1 2026 Earnings Narrower Loss Disappoints Shares Edge Higher CaliberCos Inc CWD Slides 211 as Stock Approaches Critical Support at 088 SSACW Warrant Surges 14 MicroCap Speculative Move at 008 Support BiomX Inc PHGE Shares Slide 13 as Key Support Level Approaches Pilgrims Pride PPC Edges Lower Amid Sector Pressure Holding Above Key Support Ares Management ARES Holds Steady Above Support Despite Marginal Gain Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Envela Corporation ELA Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock Waton Financial WTF Slips 49 Key Support and Resistance Levels in Focus MSBIP Q1 2026 Earnings Preferred Shares Deliver Strong EPS Beat Amid Steady Market Reception NTST Q1 2026 Earnings EPS Miss Amid Challenging Market Conditions ZWS Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency in Water Solutions Sector Hut 8 Corp HUT Q3 2024 Earnings EPS Beats Estimates Despite Continued Losses Dolly Varden Silver Corporation Q4 2025 Earnings Exploration Progress Overshadowed by WiderThanExpected Loss BOH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment Alzamend Neuro Inc ALZN Q1 2026 Earnings NarrowerthanExpected Loss as EarlyStage Biotech Continues RD Focus